Recent Developments in Antimicrobial-Peptide-Conjugated Gold Nanoparticles

Bioconjugate Chemistry

Volumn 28, Issue 11, 2017, Pages 2673-2686

  Rajchakit, Urawadee ^a   Sarojini, Vijayalekshmi ^a  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG DELIVERY; FIBER OPTIC SENSORS; GOLD NANOPARTICLES; METAL NANOPARTICLES; MICROORGANISMS; PEPTIDES;

ANTI-MICROBIAL ACTIVITY; ANTIMICROBIAL PEPTIDE; CONJUGATION CHEMISTRY; DRUG-RESISTANT PATHOGENS; FINE TUNING; GOLD NANOPARTICLE; GOLD NANOPARTICLES; METALLIC NANOPARTICLES; MULTIDRUG RESISTANTS; NANOPARTICLE CONJUGATE;

ANTIMICROBIAL AGENTS;

BIS(VANCOMYCIN)CYSTAMIDE; CECROPIN; ESCULENTIN 1A; GOLD NANOPARTICLE; MELITTIN; POLYPEPTIDE ANTIBIOTIC AGENT; UNCLASSIFIED DRUG; VANCOMYCIN; VANCOMYCIN DERIVATIVE; ANTIMICROBIAL CATIONIC PEPTIDE; GOLD; METAL NANOPARTICLE; NANOCONJUGATE;

ANTIMICROBIAL ACTIVITY; DRUG CLASSIFICATION; DRUG CONJUGATION; DRUG MECHANISM; ENTEROCOCCUS FAECALIS; NONHUMAN; PSEUDOMONAS AERUGINOSA; REVIEW; STAPHYLOCOCCUS AUREUS; ANIMAL; BACTERIAL INFECTION; BACTERIUM; CHEMISTRY; DRUG DEVELOPMENT; DRUG EFFECTS; HUMAN; MOLECULAR MODEL;

ANIMALS; ANTIMICROBIAL CATIONIC PEPTIDES; BACTERIA; BACTERIAL INFECTIONS; DRUG DISCOVERY; GOLD; HUMANS; METAL NANOPARTICLES; MODELS, MOLECULAR; NANOCONJUGATES;

EID: 85034268814     PISSN: 10431802     EISSN: 15204812     Source Type: Journal    
DOI: 10.1021/acs.bioconjchem.7b00368     Document Type: Review

References (205)

1. Aloush, V., Navon-Venezia, S., Seigman-Igra, Y., Cabili, S., and Carmeli, Y. (2006) Multidrug-resistant Pseudomonas aeruginosa: risk factors and clinical impact Antimicrob. Agents Chemother. 50, 43-48 10.1128/AAC.50.1.43-48.2006
2. Manchanda, V., Sanchaita, S., and Singh, N. (2010) Multidrug resistant acinetobacter J. Glob. Infect. Dis. 2, 291-304 10.4103/0974-777X.68538
3. Guilhelmelli, F., Vilela, N., Albuquerque, P., Derengowski, L. D., Silva-Pereira, I., and Kyaw, C. M. (2013) Antibiotic development challenges: the various mechanisms of action of antimicrobial peptides and of bacterial resistance. Front. Microbiol. 4. 10.3389/fmicb.2013.00353
4. WHO. ((2014) Antimicrobial Resistance. Global Report on Surveillance; WHO: Geneva, Switzerland, 2-7.
5. WHO. ((2015) Urgent action needed to prevent a return to pre-antibiotic era: WHO; http://www.searo.who.int/timorleste/mediacentre/prevent-a-return-to-pre-antibiotic-era-who/en/ (accessed June 25, 2017).
6. O'Neill, J. (2014) Antimicrobial Resistance: Tackling a Crisis for the Health and Wealth of Nations; HM Government: London, United Kingdom.
7. Hoiby, N., Bjarnsholt, T., Givskov, M., Molin, S., and Ciofu, O. (2010) Antibiotic resistance of bacterial biofilms Int. J. Antimicrob. Agents 35, 322-332 10.1016/j.ijantimicag.2009.12.011
8. Otter, J. A., Vickery, K., Walker, J. T., deLancey Pulcini, E., Stoodley, P., Goldenberg, S. D., Salkeld, J. A., Chewins, J., Yezli, S., and Edgeworth, J. D. (2015) Surface-attached cells, biofilms and biocide susceptibility: implications for hospital cleaning and disinfection J. Hosp. Infect. 89, 16-27 10.1016/j.jhin.2014.09.008
9. Hancock, R. E. and Chapple, D. S. (1999) Peptide antibiotics Antimicrob. Agents Chemother. 43, 1317-1323
10. Wang, S., Zeng, X. F., Yang, Q., and Qiao, S. Y. (2016) Antimicrobial Peptides as Potential Alternatives to Antibiotics in Food Animal Industry Int. J. Mol. Sci. 17, 603 10.3390/ijms17050603
11. van t Hof, W., Veerman, E. C. I., Helmerhorst, E. J., and Amerongen, A. V. N. (2001) Antimicrobial peptides: Properties and applicability Biol. Chem. 382, 597-619 10.1515/BC.2001.072
12. Marr, A. K., Gooderham, W. J., and Hancock, R. E. W. (2006) Antibacterial peptides for therapeutic use: obstacles and realistic outlook Curr. Opin. Pharmacol. 6, 468-472 10.1016/j.coph.2006.04.006
13. Zhang, L.-j. and Gallo, R. L. (2016) Antimicrobial peptides Curr. Biol. 26, R14-R19 10.1016/j.cub.2015.11.017
14. Brandelli, A. (2012) Nanostructures as promising tools for delivery of antimicrobial peptides Mini-Rev. Med. Chem. 12, 731-741 10.2174/138955712801264774
15. Kang, S. J., Park, S. J., Mishig-Ochir, T., and Lee, B. J. (2014) Antimicrobial peptides: therapeutic potentials Expert Rev. Anti-Infect. Ther. 12, 1477-1486 10.1586/14787210.2014.976613
16. Brogden, N. K. and Brogden, K. A. (2011) Will new generations of modified antimicrobial peptides improve their potential as pharmaceuticals? Int. J. Antimicrob. Agents 38, 217-225 10.1016/j.ijantimicag.2011.05.004
17. Fosgerau, K. and Hoffmann, T. (2015) Peptide therapeutics: current status and future directions Drug Discovery Today 20, 122-128 10.1016/j.drudis.2014.10.003
18. Kaspar, A. A. and Reichert, J. M. (2013) Future directions for peptide therapeutics development Drug Discovery Today 18, 807-817 10.1016/j.drudis.2013.05.011
19. White, C. J. and Yudin, A. K. (2011) Contemporary strategies for peptide macrocyclization Nat. Chem. 3, 509-524 10.1038/nchem.1062
20. Simerska, P., Moyle, P. M., and Toth, I. (2011) Modern lipid-, carbohydrate-, and peptide-based delivery systems for peptide, vaccine, and gene products Med. Res. Rev. 31, 520-547 10.1002/med.20191
21. Thayer, A. M. (2011) Improving Peptides Chem. Eng. News 89, 13-20 10.1021/cen-v089n022.p013
22. Raghunath, A. and Perumal, E. (2017) Metal oxide nanoparticles as antimicrobial agents: a promise for the future Int. J. Antimicrob. Agents 49, 137-152 10.1016/j.ijantimicag.2016.11.011
23. Azam, A., Ahmed, A. S., Oves, M., Khan, M. S., Habib, S. S., and Memic, A. (2012) Antimicrobial activity of metal oxide nanoparticles against Gram-positive and Gram-negative bacteria: a comparative study Int. J. Nanomed. 7, 6003-6009 10.2147/IJN.S35347
24. Wang, L., Hu, C., and Shao, L. (2017) The antimicrobial activity of nanoparticles: present situation and prospects for the future Int. J. Nanomed. 12, 1227-1249 10.2147/IJN.S121956
25. Singh, M., Singh, S., Prasad, S., and Gambhir, I. S. (2008) Nanotechnology in medicine and antibacterial effect of silver nanoparticles Dig. J. Nanomater. Biostruct. 3, 115-122
26. Gordon, O., Slenters, T. V., Brunetto, P. S., Villaruz, A. E., Sturdevant, D. E., Otto, M., Landmann, R., and Fromm, K. M. (2010) Silver Coordination Polymers for Prevention of Implant Infection: Thiol Interaction, Impact on Respiratory Chain Enzymes, and Hydroxyl Radical Induction Antimicrob. Agents Chemother. 54, 4208-4218 10.1128/AAC.01830-09
27. Zhao, Y. Y., Tian, Y., Cui, Y., Liu, W. W., Ma, W. S., and Jiang, X. Y. (2010) Small Molecule-Capped Gold Nanoparticles as Potent Antibacterial Agents That Target Gram-Negative Bacteria J. Am. Chem. Soc. 132, 12349-12356 10.1021/ja1028843
28. Allahverdiyev, A. M., Kon, K. V., Abamor, E. S., Bagirova, M., and Rafailovich, M. (2011) Coping with antibiotic resistance: combining nanoparticles with antibiotics and other antimicrobial agents Expert Rev. Anti-Infect. Ther. 9, 1035-1052 10.1586/eri.11.121
29. Vega-Villa, K. R., Takemoto, J. K., Yanez, J. A., Remsberg, C. M., Forrest, M. L., and Davies, N. M. (2008) Clinical toxicities of nanocarrier systems Adv. Drug Delivery Rev. 60, 929-938 10.1016/j.addr.2007.11.007
30. De Jong, W. H. and Borm, P. J. A. (2008) Drug delivery and nanoparticles: Applications and hazards Int. J. Nanomed. 3, 133-149 10.2147/IJN.S596
31. Yang, X., Yang, M., Pang, B., Vara, M., and Xia, Y. (2015) Gold Nanomaterials at Work in Biomedicine Chem. Rev. 115, 10410-10488 10.1021/acs.chemrev.5b00193
32. Min, Y., Caster, J. M., Eblan, M. J., and Wang, A. Z. (2015) Clinical translation of nanomedicine Chem. Rev. 115, 11147-11190 10.1021/acs.chemrev.5b00116
33. Alkilany, A. M. and Murphy, C. J. (2010) Toxicity and cellular uptake of gold nanoparticles: what we have learned so far? J. Nanopart. Res. 12, 2313-2333 10.1007/s11051-010-9911-8
34. Liu, J. B., Yu, M. X., Zhou, C., and Zheng, J. (2013) Renal clearable inorganic nanoparticles: a new frontier of bionanotechnology Mater. Today 16, 477-486 10.1016/j.mattod.2013.11.003
35. Tang, S. H., Peng, C. Q., Xu, J., Du, B. J., Wang, Q. X., Vinluan, R. D., Yu, M. X., Kim, M. J., and Zheng, J. (2016) Tailoring Renal Clearance and Tumor Targeting of Ultrasmall Metal Nanoparticles with Particle Density Angew. Chem., Int. Ed. 55, 16039-16043 10.1002/anie.201609043
36. Troutman, T. S., Barton, J. K., and Romanowski, M. (2008) Biodegradable plasmon resonant nanoshells Adv. Mater. 20, 2604-2608 10.1002/adma.200703026
37. Chou, L. Y. T., Zagorovsky, K., and Chan, W. C. W. (2014) DNA assembly of nanoparticle superstructures for controlled biological delivery and elimination Nat. Nanotechnol. 9, 148-155 10.1038/nnano.2013.309
38. Zasloff, M. (2002) Antimicrobial peptides of multicellular organisms Nature 415, 389-395 10.1038/415389a
39. Hancock, R. E. and Sahl, H. G. (2006) Antimicrobial and host-defense peptides as new anti-infective therapeutic strategies Nat. Biotechnol. 24, 1551-1557 10.1038/nbt1267
40. Strieker, M. and Marahiel, M. A. (2009) The structural diversity of acidic lipopeptide antibiotics ChemBioChem 10, 607-616 10.1002/cbic.200800546
41. Robbel, L. and Marahiel, M. A. (2010) Daptomycin, a bacterial lipopeptide synthesized by a nonribosomal machinery J. Biol. Chem. 285, 27501-27508 10.1074/jbc.R110.128181
42. Vaara, M. (2010) Polymyxins and their novel derivatives Curr. Opin. Microbiol. 13, 574-581 10.1016/j.mib.2010.09.002
43. Landman, D., Georgescu, C., Martin, D. A., and Quale, J. (2008) Polymyxins revisited Clin. Microbiol. Rev. 21, 449-465 10.1128/CMR.00006-08
44. De Zoysa, G. H., Cameron, A. J., Hegde, V. V., Raghothama, S., and Sarojini, V. (2015) Antimicrobial peptides with potential for biofilm eradication: synthesis and structure activity relationship studies of battacin peptides J. Med. Chem. 58, 625-639 10.1021/jm501084q
45. Becker, B., Butler, M. S., Hansford, K. A., Gallardo-Godoy, A., Elliott, A. G., Huang, J. X., Edwards, D. J., Blaskovich, M. A. T., and Cooper, M. A. (2017) Synthesis of octapeptin C4 and biological profiling against NDM-1 and polymyxin-resistant bacteria Bioorg. Med. Chem. Lett. 27, 2407-2409 10.1016/j.bmcl.2017.04.027
46. Cochrane, S. A., Li, X., He, S., Yu, M., Wu, M., and Vederas, J. C. (2015) Synthesis of Tridecaptin-Antibiotic Conjugates with in Vivo Activity against Gram-Negative Bacteria J. Med. Chem. 58, 9779-9785 10.1021/acs.jmedchem.5b01578
47. Cochrane, S. A., Lohans, C. T., Brandelli, J. R., Mulvey, G., Armstrong, G. D., and Vederas, J. C. (2014) Synthesis and structure-activity relationship studies of N-terminal analogues of the antimicrobial peptide tridecaptin A(1) J. Med. Chem. 57, 1127-1131 10.1021/jm401779d
48. Brogden, K. A. (2005) Antimicrobial peptides: pore formers or metabolic inhibitors in bacteria? Nat. Rev. Microbiol. 3, 238-250 10.1038/nrmicro1098
49. Nguyen, L. T., Haney, E. F., and Vogel, H. J. (2011) The expanding scope of antimicrobial peptide structures and their modes of action Trends Biotechnol. 29, 464-472 10.1016/j.tibtech.2011.05.001
50. Andersson, M., Boman, A., and Boman, H. G. (2003) Ascaris nematodes from pig and human make three antibacterial peptides: isolation of cecropin P1 and two ASABF peptides Cell. Mol. Life Sci. 60, 599-606 10.1007/s000180300051
51. Agerberth, B., Gunne, H., Odeberg, J., Kogner, P., Boman, H. G., and Gudmundsson, G. H. (1995) FALL-39, a putative human peptide antibiotic, is cysteine-free and expressed in bone marrow and testis Proc. Natl. Acad. Sci. U. S. A. 92, 195-199 10.1073/pnas.92.1.195
52. Berkowitz, B. A., Bevins, C. L., and Zasloff, M. A. (1990) Magainins: a new family of membrane-active host defense peptides Biochem. Pharmacol. 39, 625-629 10.1016/0006-2952(90)90138-B
53. Zasloff, M. (1987) Magainins, a class of antimicrobial peptides from Xenopus skin: isolation, characterization of two active forms, and partial cDNA sequence of a precursor Proc. Natl. Acad. Sci. U. S. A. 84, 5449-5453 10.1073/pnas.84.15.5449
54. Mygind, P. H., Fischer, R. L., Schnorr, K. M., Hansen, M. T., Sonksen, C. P., Ludvigsen, S., Raventos, D., Buskov, S., Christensen, B., and De Maria, L. et al. 2005, Plectasin is a peptide antibiotic with therapeutic potential from a saprophytic fungus Nature 437, 975-980 10.1038/nature04051
55. Ganz, T. (2003) Defensins: antimicrobial peptides of innate immunity Nat. Rev. Immunol. 3, 710-720 10.1038/nri1180
56. Kokryakov, V. N., Harwig, S. S., Panyutich, E. A., Shevchenko, A. A., Aleshina, G. M., Shamova, O. V., Korneva, H. A., and Lehrer, R. I. (1993) Protegrins: leukocyte antimicrobial peptides that combine features of corticostatic defensins and tachyplesins FEBS Lett. 327, 231-236 10.1016/0014-5793(93)80175-T
57. Falla, T. J., Karunaratne, D. N., and Hancock, R. E. (1996) Mode of action of the antimicrobial peptide indolicidin J. Biol. Chem. 271, 19298-19303 10.1074/jbc.271.32.19298
58. Frank, R. W., Gennaro, R., Schneider, K., Przybylski, M., and Romeo, D. (1990) Amino acid sequences of two proline-rich bactenecins. Antimicrobial peptides of bovine neutrophils J. Biol. Chem. 265, 18871-18874
59. Dings, R. P., Haseman, J. R., Leslie, D. B., Luong, M., Dunn, D. L., and Mayo, K. H. (2013) Bacterial membrane disrupting dodecapeptide SC4 improves survival of mice challenged with Pseudomonas aeruginosa Biochim. Biophys. Acta, Gen. Subj. 1830, 3454-3457 10.1016/j.bbagen.2013.02.002
60. Nakamura, T., Furunaka, H., Miyata, T., Tokunaga, F., Muta, T., Iwanaga, S., Niwa, M., Takao, T., and Shimonishi, Y. (1988) Tachyplesin, a class of antimicrobial peptide from the hemocytes of the horseshoe crab (Tachypleus tridentatus). Isolation and chemical structure J. Biol. Chem. 263, 16709-16713
61. Xu, F., Meng, K., Wang, Y. R., Luo, H. Y., Yang, P. L., Wu, N. F., Fan, Y. L., and Yao, B. (2008) Eukaryotic expression and antimicrobial spectrum determination of the peptide tachyplesin II Protein Expression Purif. 58, 175-183 10.1016/j.pep.2007.12.007
62. Scott, M. G., Yan, H., and Hancock, R. E. (1999) Biological properties of structurally related alpha-helical cationic antimicrobial peptides Infect. Immun. 67, 2005-2009
63. Scott, M. G., Gold, M. R., and Hancock, R. E. (1999) Interaction of cationic peptides with lipoteichoic acid and gram-positive bacteria Infect. Immun. 67, 6445-6453
64. Epand, R. M. and Epand, R. F. (2009) Lipid domains in bacterial membranes and the action of antimicrobial agents Biochim. Biophys. Acta, Biomembr. 1788, 289-294 10.1016/j.bbamem.2008.08.023
65. Glukhov, E., Stark, M., Burrows, L. L., and Deber, C. M. (2005) Basis for selectivity of cationic antimicrobial peptides for bacterial versus mammalian membranes J. Biol. Chem. 280, 33960-33967 10.1074/jbc.M507042200
66. Verkleij, A. J., Zwaal, R. F., Roelofsen, B., Comfurius, P., Kastelijn, D., and van Deenen, L. L. (1973) The asymmetric distribution of phospholipids in the human red cell membrane. A combined study using phospholipases and freeze-etch electron microscopy Biochim. Biophys. Acta, Biomembr. 323, 178-193 10.1016/0005-2736(73)90143-0
67. Matsuzaki, K. (1999) Why and how are peptide-lipid interactions utilized for self-defense? Magainins and tachyplesins as archetypes Biochim. Biophys. Acta, Biomembr. 1462, 1-10 10.1016/S0005-2736(99)00197-2
68. Matsuzaki, K. (2009) Control of cell selectivity of antimicrobial peptides Biochim. Biophys. Acta, Biomembr. 1788, 1687-1692 10.1016/j.bbamem.2008.09.013
69. Oren, Z. and Shai, Y. (1997) Selective lysis of bacteria but not mammalian cells by diastereomers of melittin: Structure-function study Biochemistry 36, 1826-1835 10.1021/bi962507l
70. Oren, Z. and Shai, Y. (2000) Cyclization of a non cell-selective cytolytic amphipatic alpha-helical peptide renders it selective to bacteria Biochemistry 39 (30) 6103-6114 10.1021/bi992408i
71. Zhu, W. L., Nan, Y. H., Hahm, K. S., and Shin, S. Y. (2007) Cell selectivity of an antimicrobial peptide melittin diastereomer with D-amino acid in the leucine zipper sequence J. Biochem Mol. Biol. 40, 1090-1094 10.5483/BMBRep.2007.40.6.1090
72. Song, Y. M., Park, Y., Lim, S. S., Yang, S. T., Woo, E. R., Park, I. S., Lee, J. S., Kim, J. I., Hahm, K. S., and Kim, Y. et al. 2005, Cell selectivity and mechanism of action of antimicrobial model peptides containing peptoid residues Biochemistry 44, 12094-12106 10.1021/bi050765p
73. Lohner, K. (2009) New strategies for novel antibiotics: peptides targeting bacterial cell membranes Gen. Physiol. Biophys. 28, 105-116 10.4149/gpb-2009-02-105
74. Huang, Y. B., He, L. Y., Li, G. R., Zhai, N. C., Jiang, H. Y., and Chen, Y. X. (2014) Role of helicity of alpha-helical antimicrobial peptides to improve specificity Protein Cell 5, 631-642 10.1007/s13238-014-0061-0
75. Gracia, S. R., Gaus, K., and Sewald, N. (2009) Synthesis of chemically modified bioactive peptides: recent advances, challenges and developments for medicinal chemistry Future Med. Chem. 1, 1289-1310 10.4155/fmc.09.97
76. Gentilucci, L., De Marco, R., and Cerisoli, L. (2010) Chemical modifications designed to improve peptide stability: incorporation of non-natural amino acids, pseudo-peptide bonds, and cyclization Curr. Pharm. Des. 16, 3185-3203 10.2174/138161210793292555
77. Ladokhin, A. S. and White, S. H. (2001) 'Detergent-like' permeabilization of anionic lipid vesicles by melittin Biochim. Biophys. Acta, Biomembr. 1514, 253-260 10.1016/S0005-2736(01)00382-0
78. Bechinger, B. (1999) The structure, dynamics and orientation of antimicrobial peptides in membranes by multidimensional solid-state NMR spectroscopy Biochim. Biophys. Acta, Biomembr. 1462, 157-183 10.1016/S0005-2736(99)00205-9
79. da Costa, J. P., Cova, M., Ferreira, R., and Vitorino, R. (2015) Antimicrobial peptides: an alternative for innovative medicines? Appl. Microbiol. Biotechnol. 99, 2023-2040 10.1007/s00253-015-6375-x
80. Yeaman, M. R. and Yount, N. Y. (2003) Mechanisms of antimicrobial peptide action and resistance Pharmacol. Rev. 55, 27-55 10.1124/pr.55.1.2
81. Epand, R. M. and Vogel, H. J. (1999) Diversity of antimicrobial peptides and their mechanisms of action Biochim. Biophys. Acta, Biomembr. 1462, 11-28 10.1016/S0005-2736(99)00198-4
82. Han, H. M., Gopal, R., and Park, Y. (2016) Design and membrane-disruption mechanism of charge-enriched AMPs exhibiting cell selectivity, high-salt resistance, and anti-biofilm properties Amino Acids 48, 505-522 10.1007/s00726-015-2104-0
83. Matsuzaki, K., Murase, O., Fujii, N., and Miyajima, K. (1996) An antimicrobial peptide, magainin 2, induced rapid flip-flop of phospholipids coupled with pore formation and peptide translocation Biochemistry 35, 11361-11368 10.1021/bi960016v
84. Ehrenstein, G. and Lecar, H. (1977) Electrically gated ionic channels in lipid bilayers Q. Rev. Biophys. 10, 1-34 10.1017/S0033583500000123
85. Oren, Z. and Shai, Y. (1998) Mode of action of linear amphipathic alpha-helical antimicrobial peptides Biopolymers 47, 451-463 10.1002/(SICI)1097-0282(1998)47:6<451::AID-BIP4>3.0.CO;2-F
86. Yang, L., Harroun, T. A., Weiss, T. M., Ding, L., and Huang, H. W. (2001) Barrel-stave model or toroidal model? A case study on melittin pores Biophys. J. 81, 1475-1485 10.1016/S0006-3495(01)75802-X
87. Pouny, Y., Rapaport, D., Mor, A., Nicolas, P., and Shai, Y. (1992) Interaction of antimicrobial dermaseptin and its fluorescently labeled analogues with phospholipid membranes Biochemistry 31, 12416-12423 10.1021/bi00164a017
88. Shai, Y. (1999) Mechanism of the binding, insertion and destabilization of phospholipid bilayer membranes by alpha-helical antimicrobial and cell non-selective membrane-lytic peptides Biochim. Biophys. Acta, Biomembr. 1462, 55-70 10.1016/S0005-2736(99)00200-X
89. Fernandez, D. I., Le Brun, A. P., Whitwell, T. C., Sani, M. A., James, M., and Separovic, F. (2012) The antimicrobial peptide aurein 1.2 disrupts model membranes via the carpet mechanism Phys. Chem. Chem. Phys. 14, 15739-15751 10.1039/c2cp43099a
90. Feynman, R. P. (1960) There's plenty of room at the bottom Engineering and science 23, 22-36 10.1201/9781420040623.sec1
91. Benelmekki, M. (2015) Designing Hybrid Nanoparticles, Morgan & Claypool Publishers, Williston, VT.
92. Taniguchi, N. (1974) On the basic concept of "nano-technology" Proc. Intl Conf Prod Eng. Tokyo, Japan Society of Precision Engineering, Part II 5-10
93. Sharon, M., Sharon, M., Pandey, S., and Oza, G. (2012) Bio-nanotechnology: Concepts and Applications, ANE Books, New Delhi, India.
94. Niemeyer, C. M. (2001) Nanoparticles, proteins, and nucleic acids: biotechnology meets materials science Angew. Chem., Int. Ed. 40, 4128-4158 10.1002/1521-3773(20011119)40:22<4128::AID-ANIE4128>3.0.CO;2-S
95. Faraji, A. H. and Wipf, P. (2009) Nanoparticles in cellular drug delivery Bioorg. Med. Chem. 17, 2950-2962 10.1016/j.bmc.2009.02.043
96. De, M., Ghosh, P. S., and Rotello, V. M. (2008) Applications of nanoparticles in biology Adv. Mater. 20, 4225-4241 10.1002/adma.200703183
97. Jiang, Z., Le, N. D., Gupta, A., and Rotello, V. M. (2015) Cell surface-based sensing with metallic nanoparticles Chem. Soc. Rev. 44, 4264-4274 10.1039/C4CS00387J
98. Galiano, K., Pleifer, C., Engelhardt, K., Brossner, G., Lackner, P., Huck, C., Lass-Florl, C., and Obwegeser, A. (2008) Silver segregation and bacterial growth of intraventricular catheters impregnated with silver nanoparticles in cerebrospinal fluid drainages Neurol. Res. 30, 285-287 10.1179/016164107X229902
99. Bystrzejewska-Piotrowska, G., Golimowski, J., and Urban, P. L. (2009) Nanoparticles: Their potential toxicity, waste and environmental management Waste Manage. 29, 2587-2595 10.1016/j.wasman.2009.04.001
100. Mor, G. K., Varghese, O. K., Paulose, M., Shankar, K., and Grimes, C. A. (2006) A review on highly ordered, vertically oriented TiO 2 nanotube arrays: fabrication, material properties, and solar energy applications Sol. Energy Mater. Sol. Cells 90, 2011-2075 10.1016/j.solmat.2006.04.007
101. Che, G. L., Lakshmi, B. B., Fisher, E. R., and Martin, C. R. (1998) Carbon nanotubule membranes for electrochemical energy storage and production Nature 393, 346-349 10.1038/30694
102. Pourmand, A. and Abdollahi, M. (2012) Current opinion on nanotoxicology Daru, J. Pharm. Sci. 20, 95 10.1186/2008-2231-20-95
103. Vishwakarma, V., Samal, S. S., and Manoharan, N. (2010) Safety and risk associated with nanoparticles-a review J. Miner. Mater. Charact. Eng. 9, 455 10.4236/jmmce.2010.95031
104. Hagens, W. I., Oomen, A. G., de Jong, W. H., Cassee, F. R., and Sips, A. J. (2007) What do we (need to) know about the kinetic properties of nanoparticles in the body? Regul. Toxicol. Pharmacol. 49, 217-229 10.1016/j.yrtph.2007.07.006
105. Nemmar, A., Hoet, P. M., Vanquickenborne, B., Dinsdale, D., Thomeer, M., Hoylaerts, M., Vanbilloen, H., Mortelmans, L., and Nemery, B. (2002) Passage of inhaled particles into the blood circulation in humans Circulation 105, 411-414
106. Takenaka, S., Karg, E., Roth, C., Schulz, H., Ziesenis, A., Heinzmann, U., Schramel, P., and Heyder, J. (2001) Pulmonary and systemic distribution of inhaled ultrafine silver particles in rats Environ. Health Perspect. 109, 547 10.1289/ehp.01109s4547
107. Yang, L. and Watts, D. J. (2005) Particle surface characteristics may play an important role in phytotoxicity of alumina nanoparticles Toxicol. Lett. 158, 122-132 10.1016/j.toxlet.2005.03.003
108. Donaldson, K., Brown, D., Clouter, A., Duffin, R., MacNee, W., Renwick, L., Tran, L., and Stone, V. (2002) The pulmonary toxicology of ultrafine particles J. Aerosol Med. 15, 213-220 10.1089/089426802320282338
109. Mostafalou, S., Mohammadi, H., Ramazani, A., and Abdollahi, M. (2013) Different biokinetics of nanomedicines linking to their toxicity; an overview Daru, J. Pharm. Sci. 21, 14 10.1186/2008-2231-21-14
110. Ghosh, P., Han, G., De, M., Kim, C. K., and Rotello, V. M. (2008) Gold nanoparticles in delivery applications Adv. Drug Delivery Rev. 60, 1307-1315 10.1016/j.addr.2008.03.016
111. Lewis, W. H. (1937) Pinocytosis by malignant cells Am. J. Cancer 29, 666-679 10.1158/ajc.1937.666
112. Swanson, J. A. (2008) Shaping cups into phagosomes and macropinosomes Nat. Rev. Mol. Cell Biol. 9, 639-649 10.1038/nrm2447
113. Shukla, R., Bansal, V., Chaudhary, M., Basu, A., Bhonde, R. R., and Sastry, M. (2005) Biocompatibility of gold nanoparticles and their endocytotic fate inside the cellular compartment: A microscopic overview Langmuir 21, 10644-10654 10.1021/la0513712
114. Connor, E. E., Mwamuka, J., Gole, A., Murphy, C. J., and Wyatt, M. D. (2005) Gold nanoparticles are taken up by human cells but do not cause acute cytotoxicity Small 1, 325-327 10.1002/smll.200400093
115. Goodman, C. M., McCusker, C. D., Yilmaz, T., and Rotello, V. M. (2004) Toxicity of gold nanoparticles functionalized with cationic and anionic side chains Bioconjugate Chem. 15, 897-900 10.1021/bc049951i
116. Fu, P. P., Xia, Q. S., Hwang, H. M., Ray, P. C., and Yu, H. T. (2014) Mechanisms of nanotoxicity: Generation of reactive oxygen species J. Food Drug Anal 22, 64-75 10.1016/j.jfda.2014.01.005
117. Gonzalez, L., Lison, D., and Kirsch-Volders, M. (2008) Genotoxicity of engineered nanomaterials: A critical review Nanotoxicology 2, 252-273 10.1080/17435390802464986
118. Pan, Y., Leifert, A., Ruau, D., Neuss, S., Bornemann, J., Schmid, G., Brandau, W., Simon, U., and Jahnen-Dechent, W. (2009) Gold Nanoparticles of Diameter 1.4 nm Trigger Necrosis by Oxidative Stress and Mitochondrial Damage Small 5, 2067-2076 10.1002/smll.200900466
119. Turner, M., Golovko, V. B., Vaughan, O. P. H., Abdulkin, P., Berenguer-Murcia, A., Tikhov, M. S., Johnson, B. F. G., and Lambert, R. M. (2008) Selective oxidation with dioxygen by gold nanoparticle catalysts derived from 55-atom clusters Nature 454, 981-983 10.1038/nature07194
120. Patra, H. K., Banerjee, S., Chaudhuri, U., Lahiri, P., and Dasgupta, A. K. (2007) Cell selective response to gold nanoparticles Nanomedicine 3, 111-119 10.1016/j.nano.2007.03.005
121. Pal, S., Mitra, K., Azmi, S., Ghosh, J. K., and Chakraborty, T. K. (2011) Towards the synthesis of sugar amino acid containing antimicrobial noncytotoxic CAP conjugates with gold nanoparticles and a mechanistic study of cell disruption Org. Biomol. Chem. 9, 4806-4810 10.1039/c1ob05338h
122. Rai, A., Pinto, S., Velho, T. R., Ferreira, A. F., Moita, C., Trivedi, U., Evangelista, M., Comune, M., Rumbaugh, K. P., and Simoes, P. N. et al. 2016, One-step synthesis of high-density peptide-conjugated gold nanoparticles with antimicrobial efficacy in a systemic infection model Biomaterials 85, 99-110 10.1016/j.biomaterials.2016.01.051
123. Casciaro, B., Moros, M., Rivera-Fernández, S., Bellelli, A., de la Fuente, J. M., and Mangoni, M. L. (2017) Gold-nanoparticles coated with the antimicrobial peptide esculentin-1a (1-21) NH 2 as a reliable strategy for antipseudomonal drugs Acta Biomater. 47, 170-181 10.1016/j.actbio.2016.09.041
124. Hainfeld, J. F., Slatkin, D. N., and Smilowitz, H. M. (2004) The use of gold nanoparticles to enhance radiotherapy in mice Phys. Med. Biol. 49, N309-N315 10.1088/0031-9155/49/18/N03
125. Niidome, T., Yamagata, M., Okamoto, Y., Akiyama, Y., Takahashi, H., Kawano, T., Katayama, Y., and Niidome, Y. (2006) PEG-modified gold nanorods with a stealth character for in vivo applications J. Controlled Release 114, 343-347 10.1016/j.jconrel.2006.06.017
126. Huang, X. L., Zhang, B., Ren, L., Ye, S. F., Sun, L. P., Zhang, Q. Q., Tan, M. C., and Chow, G. M. (2008) In vivo toxic studies and biodistribution of near infrared sensitive Au-Au(2)S nanoparticles as potential drug delivery carriers J. Mater. Sci.: Mater. Med. 19, 2581-2588 10.1007/s10856-007-3210-7
127. Sun, T. M., Zhang, Y. S., Pang, B., Hyun, D. C., Yang, M. X., and Xia, Y. N. (2014) Engineered Nanoparticles for Drug Delivery in Cancer Therapy Angew. Chem., Int. Ed. 53, 12320-12364 10.1002/anie.201403036
128. Choi, H. S., Liu, W., Misra, P., Tanaka, E., Zimmer, J. P., Ipe, B. I., Bawendi, M. G., and Frangioni, J. V. (2007) Renal clearance of quantum dots Nat. Biotechnol. 25, 1165-1170 10.1038/nbt1340
129. Hajipour, M. J., Fromm, K. M., Ashkarran, A. A., de Aberasturi, D. J., de Larramendi, I. R., Rojo, T., Serpooshan, V., Parak, W. J., and Mahmoudi, M. (2012) Antibacterial properties of nanoparticles Trends Biotechnol. 30, 499-511 10.1016/j.tibtech.2012.06.004
130. Miller, K. P., Wang, L., Benicewicz, B. C., and Decho, A. W. (2015) Inorganic nanoparticles engineered to attack bacteria Chem. Soc. Rev. 44, 7787-7807 10.1039/C5CS00041F
131. Huh, A. J. and Kwon, Y. J. (2011) ″Nanoantibiotics″: A new paradigm for treating infectious diseases using nanomaterials in the antibiotics resistant era J. Controlled Release 156, 128-145 10.1016/j.jconrel.2011.07.002
132. Chopra, I. (2007) The increasing use of silver-based products as antimicrobial agents: a useful development or a cause for concern? J. Antimicrob. Chemother. 59, 587-590 10.1093/jac/dkm006
133. Maple, P. A. C., Hamiltonmiller, J. M. T., and Brumfitt, W. (1992) Comparison of the Invitro Activities of the Topical Antimicrobials Azelaic Acid, Nitrofurazone, Silver Sulfadiazine and Mupirocin against Methicillin-Resistant Staphylococcus-Aureus J. Antimicrob. Chemother. 29, 661-668 10.1093/jac/29.6.661
134. Ulbrich, K., Hola, K., Subr, V., Bakandritsos, A., Tucek, J., and Zboril, R. (2016) Targeted Drug Delivery with Polymers and Magnetic Nanoparticles: Covalent and Noncovalent Approaches, Release Control, and Clinical Studies Chem. Rev. 116, 5338-5431 10.1021/acs.chemrev.5b00589
135. Gao, W., Thamphiwatana, S., Angsantikul, P., and Zhang, L. (2014) Nanoparticle approaches against bacterial infections Wiley Interdiscip Rev. Nanomed Nanobiotechnol 6, 532-547 10.1002/wnan.1282
136. Liu, P. F., Lo, C. W., Chen, C. H., Hsieh, M. F., and Huang, C. M. (2009) Use of Nanoparticles as Therapy for Methicillin-Resistant Staphylococcus aureus Infections Curr. Drug Metab. 10, 875-884 10.2174/138920009790274522
137. Pissuwan, D., Niidome, T., and Cortie, M. B. (2011) The forthcoming applications of gold nanoparticles in drug and gene delivery systems J. Controlled Release 149, 65-71 10.1016/j.jconrel.2009.12.006
138. Lewinski, N., Colvin, V., and Drezek, R. (2008) Cytotoxicity of nanoparticles Small 4, 26-49 10.1002/smll.200700595
139. Wang, B., Feng, W. Y., Wang, T. C., Jia, G., Wang, M., Shi, J. W., Zhang, F., Zhao, Y. L., and Chai, Z. F. (2006) Acute toxicity of nano- and micro-scale zinc powder in healthy adult mice Toxicol. Lett. 161, 115-123 10.1016/j.toxlet.2005.08.007
140. Zhu, M. T., Feng, W. Y., Wang, B., Wang, T. C., Gu, Y. Q., Wang, M., Wang, Y., Ouyang, H., Zhao, Y. L., and Chai, Z. F. (2008) Comparative study of pulmonary responses to nano- and submicron-sized ferric oxide in rats Toxicology 247, 102-111 10.1016/j.tox.2008.02.011
141. Pal, I., Brahmkhatri, V. P., Bera, S., Bhattacharyya, D., Quirishi, Y., Bhunia, A., and Atreya, H. S. (2016) Enhanced stability and activity of an antimicrobial peptide in conjugation with silver nanoparticle J. Colloid Interface Sci. 483, 385-393 10.1016/j.jcis.2016.08.043
142. Liu, L. H., Yang, J., Xie, J. P., Luo, Z. T., Jiang, J., Yang, Y. Y., and Liu, S. M. (2013) The potent antimicrobial properties of cell penetrating peptide-conjugated silver nanoparticles with excellent selectivity for Gram-positive bacteria over erythrocytes Nanoscale 5, 3834-3840 10.1039/c3nr34254a
143. Veerapandian, M. and Yuna, K. (2009) The state of the art in biomaterials as nanobiopharmaceuticals Dig. J. Nanomater. Biostruct. 4, 243-262
144. Veerapandian, M. and Yun, K. (2011) Functionalization of biomolecules on nanoparticles: specialized for antibacterial applications Appl. Microbiol. Biotechnol. 90, 1655-1667 10.1007/s00253-011-3291-6
145. Zhang, W. X., Zhang, Z. Z., and Zhang, Y. G. (2011) The application of carbon nanotubes in target drug delivery systems for cancer therapies. Nanoscale Res. Lett. 6. 555 10.1186/1556-276X-6-555
146. Kesharwani, P., Jain, K., and Jain, N. K. (2014) Dendrimer as nanocarrier for drug delivery Prog. Polym. Sci. 39, 268-307 10.1016/j.progpolymsci.2013.07.005
147. Torchilin, V. P. (2005) Recent advances with liposomes as pharmaceutical carriers Nat. Rev. Drug Discovery 4, 145-160 10.1038/nrd1632
148. Walling, M. A., Novak, J. A., and Shepard, J. R. E. (2009) Quantum Dots for Live Cell and In Vivo Imaging Int. J. Mol. Sci. 10, 441-491 10.3390/ijms10020441
149. Jhaveri, A. M. and Torchilin, V. P. (2014) Multifunctional polymeric micelles for delivery of drugs and siRNA. Front. Pharmacol. 5. 10.3389/fphar.2014.00077
150. Masood, F. (2016) Polymeric nanoparticles for targeted drug delivery system for cancer therapy Mater. Sci. Eng., C 60, 569-578 10.1016/j.msec.2015.11.067
151. Anselmo, A. C. and Mitragotri, S. (2016) Nanoparticles in the clinic Bioeng. Transl. Med. 1, 10-29 10.1002/btm2.10003
152. Cortajarena, A. L., Ortega, D., Ocampo, S. M., Gonzalez-García, A., Couleaud, P., Miranda, R., Belda-Iniesta, C., and Ayuso-Sacido, A. (2014) Engineering iron oxide nanoparticles for clinical settings Nanobiomedicine 1, 2 10.5772/58841
153. Barenholz, Y. C. (2012) Doxil®-the first FDA-approved nano-drug: lessons learned J. Controlled Release 160, 117-134 10.1016/j.jconrel.2012.03.020
154. Hua, S. (2015) Lipid-based nano-delivery systems for skin delivery of drugs and bioactives Front. Pharmacol. 6, 219 10.3389/fphar.2015.00219
155. AIDS Treatment News. (1996) Kaposi's Sarcoma: DaunoXome Approved. AIDS Treatment News, 3-4.
156. AIDS Patient Care. (1995) DOXIL Approved by FDA. AIDS Patient Care 9, 306. 10.1089/apc.1995.9.306
157. Udhrain, A., Skubitz, K. M., and Northfelt, D. W. (2007) Pegylated liposomal doxorubicin in the treatment of AIDS-related Kaposi's sarcoma Int. J. Nanomedicine 2, 345-352
158. Allen, T. M. and Cullis, P. R. (2013) Liposomal drug delivery systems: from concept to clinical applications Adv. Drug Delivery Rev. 65, 36-48 10.1016/j.addr.2012.09.037
159. Zharov, V. P., Mercer, K. E., Galitovskaya, E. N., and Smeltzer, M. S. (2006) Photothermal nanotherapeutics and nanodiagnostics for selective killing of bacteria targeted with gold nanoparticles Biophys. J. 90, 619-627 10.1529/biophysj.105.061895
160. Zharov, V. P., Galitovskaya, E. N., Johnson, C., and Kelly, T. (2005) Synergistic enhancement of selective nanophotothermolysis with gold nanoclusters: potential for cancer therapy Lasers Surg. Med. 37, 219-226 10.1002/lsm.20223
161. Keren, S., Zavaleta, C., Cheng, Z., de la Zerda, A., Gheysens, O., and Gambhir, S. S. (2008) Noninvasive molecular imaging of small living subjects using Raman spectroscopy Proc. Natl. Acad. Sci. U. S. A. 105, 5844-5849 10.1073/pnas.0710575105
162. Durr, N. J., Larson, T., Smith, D. K., Korgel, B. A., Sokolov, K., and Ben-Yakar, A. (2007) Two-photon luminescence imaging of cancer cells using molecularly targeted gold nanorods Nano Lett. 7, 941-945 10.1021/nl062962v
163. Huang, X. H., El-Sayed, I. H., Qian, W., and El-Sayed, M. A. (2007) Cancer cells assemble and align gold nanorods conjugated to antibodies to produce highly enhanced, sharp, and polarized surface Raman spectra: A potential cancer diagnostic marker Nano Lett. 7, 1591-1597 10.1021/nl070472c
164. Tong, L., Zhao, Y., Huff, T. B., Hansen, M. N., Wei, A., and Cheng, J. X. (2007) Gold nanorods mediate tumor cell death by compromising membrane integrity Adv. Mater. 19, 3136-3141 10.1002/adma.200701974
165. Wang, Y., Qian, W. P., Tan, Y., and Ding, S. H. (2008) A label-free biosensor based on gold nanoshell monolayers for monitoring biomolecular interactions in diluted whole blood Biosens. Bioelectron. 23, 1166-1170 10.1016/j.bios.2007.10.020
166. Su, C. H., Sheu, H. S., Lin, C. Y., Huang, C. C., Lo, Y. W., Pu, Y. C., Weng, J. C., Shieh, D. B., Chen, J. H., and Yeh, C. S. (2007) Nanoshell magnetic resonance imaging contrast agents J. Am. Chem. Soc. 129, 2139-2146 10.1021/ja0672066
167. Hirsch, L. R., Stafford, R. J., Bankson, J. A., Sershen, S. R., Rivera, B., Price, R. E., Hazle, J. D., Halas, N. J., and West, J. L. (2003) Nanoshell-mediated near-infrared thermal therapy of tumors under magnetic resonance guidance Proc. Natl. Acad. Sci. U. S. A. 100, 13549-13554 10.1073/pnas.2232479100
168. Sershen, S. R., Westcott, S. L., Halas, N. J., and West, J. L. (2000) Temperature-sensitive polymer-nanoshell composites for photothermally modulated drug delivery J. Biomed. Mater. Res. 51, 293-298 10.1002/1097-4636(20000905)51:3<293::AID-JBM1>3.0.CO;2-T
169. Chen, J. Y., Wang, D. L., Xi, J. F., Au, L., Siekkinen, A., Warsen, A., Li, Z. Y., Zhang, H., Xia, Y. N., and Li, X. D. (2007) Immuno gold nanocages with tailored optical properties for targeted photothermal destruction of cancer cells Nano Lett. 7, 1318-1322 10.1021/nl070345g
170. Valetti, S., Mura, S., Noiray, M., Arpicco, S., Dosio, F., Vergnaud, J., Desmaele, D., Stella, B., and Couvreur, P. (2014) Peptide Conjugation: Before or After Nanoparticle Formation? Bioconjugate Chem. 25, 1971-1983 10.1021/bc5003423
171. Katz, E. and Willner, I. (2004) Integrated nanoparticle-biomolecule hybrid systems: synthesis, properties, and applications Angew. Chem., Int. Ed. 43, 6042-6108 10.1002/anie.200400651
172. Jazayeri, M. H., Amani, H., Pourfatollah, A. A., Pazoki-Toroudi, H., and Sedighimoghaddam, B. (2016) Various methods of gold nanoparticles (GNPs) conjugation to antibodies Sens. Biosensing Res. 9, 17-22 10.1016/j.sbsr.2016.04.002
173. Ravindran, A., Chandran, P., and Khan, S. S. (2013) Biofunctionalized silver nanoparticles: advances and prospects Colloids Surf., B 105, 342-352 10.1016/j.colsurfb.2012.07.036
174. Lutz, J. F. and Zarafshani, Z. (2008) Efficient construction of therapeutics, bioconjugates, biomaterials and bioactive surfaces using azide-alkyne ″click″ chemistry Adv. Drug Delivery Rev. 60, 958-970 10.1016/j.addr.2008.02.004
175. Liang, L. Y. and Astruc, D. (2011) The copper(I)-catalyzed alkyne-azide cycloaddition (CuAAC) ″click″ reaction and its applications. An overview Coord. Chem. Rev. 255, 2933-2945 10.1016/j.ccr.2011.06.028
176. Reinhardt, A. and Neundorf, I. (2016) Design and application of antimicrobial peptide conjugates Int. J. Mol. Sci. 17, 701 10.3390/ijms17050701
177. Tielens, F. and Santos, E. (2010) AuS and SH Bond Formation/Breaking during the Formation of Alkanethiol SAMs on Au(111): A Theoretical Study J. Phys. Chem. C 114, 9444-9452 10.1021/jp102036r
178. Xue, Y. R., Li, X., Li, H. B., and Zhang, W. K. (2014) Quantifying thiol-gold interactions towards the efficient strength control Nat. Commun. 5, 4348 10.1038/ncomms5348
179. Wadhwani, P., Heidenreich, N., Podeyn, B., Burck, J., and Ulrich, A. S. (2017) Antibiotic gold: tethering of antimicrobial peptides to gold nanoparticles maintains conformational flexibility of peptides and improves trypsin susceptibility Biomater. Sci. 5, 817-827 10.1039/C7BM00069C
180. Rai, A., Pinto, S., Evangelista, M. B., Gil, H., Kallip, S., Ferreira, M. G., and Ferreira, L. (2016) High-density antimicrobial peptide coating with broad activity and low cytotoxicity against human cells Acta Biomater. 33, 64-77 10.1016/j.actbio.2016.01.035
181. Gu, H. W., Ho, P. L., Tong, E., Wang, L., and Xu, B. (2003) Presenting vancomycin on nanoparticles to enhance antimicrobial activities Nano Lett. 3, 1261-1263 10.1021/nl034396z
182. Lai, H. Z., Chen, W. Y., Wu, C. Y., and Chen, Y. C. (2015) Potent Antibacterial Nanoparticles for Pathogenic Bacteria ACS Appl. Mater. Interfaces 7, 2046-2054 10.1021/am507919m
183. Amanulla, M. F., Girilal, M., Mahdy, S. A., Somsundar, S. S., Venkatesan, R., and Kalaichelvan, P. T. (2011) Vancomycin bound biogenic gold nanoparticles: A different perspective for development of anti VRSA agents Process Biochem. 46, 636-641 10.1016/j.procbio.2010.11.001
184. Pornpattananangkul, D., Zhang, L., Olson, S., Aryal, S., Obonyo, M., Vecchio, K., Huang, C. M., and Zhang, L. F. (2011) Bacterial Toxin-Triggered Drug Release from Gold Nanoparticle-Stabilized Liposomes for the Treatment of Bacterial Infection J. Am. Chem. Soc. 133, 4132-4139 10.1021/ja111110e
185. Yeom, J. H., Lee, B., Kim, D., Lee, J. K., Kim, S., Bae, J., Park, Y., and Lee, K. (2016) Gold nanoparticle-DNA aptamer conjugate-assisted delivery of antimicrobial peptide effectively eliminates intracellular Salmonella enterica serovar Typhimurium Biomaterials 104, 43-51 10.1016/j.biomaterials.2016.07.009
186. Peng, L. H., Huang, Y. F., Zhang, C. Z., Niu, J., Chen, Y., Chu, Y., Jiang, Z. H., Gao, J. Q., and Mao, Z. W. (2016) Integration of antimicrobial peptides with gold nanoparticles as unique non-viral vectors for gene delivery to mesenchymal stem cells with antibacterial activity Biomaterials 103, 137-149 10.1016/j.biomaterials.2016.06.057
187. Ruden, S., Hilpert, K., Berditsch, M., Wadhwani, P., and Ulrich, A. S. (2009) Synergistic Interaction between Silver Nanoparticles and Membrane-Permeabilizing Antimicrobial Peptides Antimicrob. Agents Chemother. 53, 3538-3540 10.1128/AAC.01106-08
188. Golubeva, O. Y., Shamova, O. V., Orlov, D. S., Pazina, T. Y., Boldina, A. S., Drozdova, I. A., and Kokryakov, V. N. (2011) Synthesis and Study of Antimicrobial Activity of Bioconjugates of Silver Nanoparticles and Endogenous Antibiotics Glass Phys. Chem. 37, 78-84 10.1134/S1087659611010056
189. Mohanty, S., Jena, P., Mehta, R., Pati, R., Banerjee, B., Patil, S., and Sonawane, A. (2013) Cationic Antimicrobial Peptides and Biogenic Silver Nanoparticles Kill Mycobacteria without Eliciting DNA Damage and Cytotoxicity in Mouse Macrophages Antimicrob. Agents Chemother. 57, 3688-3698 10.1128/AAC.02475-12
190. Zhang, T. L., Wang, L. M., Chen, Q., and Chen, C. Y. (2014) Cytotoxic Potential of Silver Nanoparticles Yonsei Med. J. 55, 283-291 10.3349/ymj.2014.55.2.283
191. Zhang, W., Shi, X., Huang, J., Zhang, Y., Wu, Z., and Xian, Y. (2012) Bacitracin-Conjugated Superparamagnetic Iron Oxide Nanoparticles: Synthesis, Characterization and Antibacterial Activity ChemPhysChem 13, 3388-3396 10.1002/cphc.201200161
192. Tarallo, R., Carberry, T. P., Falanga, A., Vitiello, M., Galdiero, S., Galdiero, M., and Weck, M. (2013) Dendrimers functionalized with membrane-interacting peptides for viral inhibition Int. J. Nanomed. 8, 521-534 10.2147/IJN.S37739
193. Pini, A., Giuliani, A., Falciani, C., Runci, Y., Ricci, C., Lelli, B., Malossi, M., Neri, P., Rossolini, G. M., and Bracci, L. (2005) Antimicrobial activity of novel dendrimeric peptides obtained by phage display selection and rational modification Antimicrob. Agents Chemother. 49, 2665-2672 10.1128/AAC.49.7.2665-2672.2005
194. Bruschi, M., Pirri, G., Giuliani, A., Nicoletto, S. F., Baster, I., Scorciapino, M. A., Casu, M., and Rinaldi, A. C. (2010) Synthesis, characterization, antimicrobial activity and LPS-interaction properties of SB041, a novel dendrimeric peptide with antimicrobial properties Peptides 31, 1459-1467 10.1016/j.peptides.2010.04.022
195. He, P. and Zhu, X. (2007) Phospholipid-assisted synthesis of size-controlled gold nanoparticles Mater. Res. Bull. 42, 1310-1315 10.1016/j.materresbull.2006.10.014
196. Verma, A., Uzun, O., Hu, Y., Hu, Y., Han, H.-S., Watson, N., Chen, S., Irvine, D. J., and Stellacci, F. (2008) Surface-structure-regulated cell-membrane penetration by monolayer-protected nanoparticles Nat. Mater. 7, 588-595 10.1038/nmat2202
197. Urban, A., Fedoruk, M., Horton, M., Radler, J., Stefani, F. D., and Feldmann, J. (2009) Controlled nanometric phase transitions of phospholipid membranes by plasmonic heating of single gold nanoparticles Nano Lett. 9, 2903-2908 10.1021/nl901201h
198. Wangoo, N., Suri, C. R., and Shekhawat, G. (2008) Interaction of gold nanoparticles with protein: a spectroscopic study to monitor protein conformational changes Appl. Phys. Lett. 92, 133104 10.1063/1.2902302
199. Chen, J., Hessler, J. A., Putchakayala, K., Panama, B. K., Khan, D. P., Hong, S., Mullen, D. G., DiMaggio, S. C., Som, A., and Tew, G. N. et al. 2009, Cationic nanoparticles induce nanoscale disruption in living cell plasma membranes J. Phys. Chem. B 113, 11179-11185 10.1021/jp9033936
200. Hall-Stoodley, L., Costerton, J. W., and Stoodley, P. (2004) Bacterial biofilms: from the natural environment to infectious diseases Nat. Rev. Microbiol. 2, 95-108 10.1038/nrmicro821
201. Stewart, P. S. (2002) Mechanisms of antibiotic resistance in bacterial biofilms Int. J. Med. Microbiol. 292, 107-113 10.1078/1438-4221-00196
202. Lewis, K. (2001) Riddle of biofilm resistance Antimicrob. Agents Chemother. 45, 999-1007 10.1128/AAC.45.4.999-1007.2001
203. Sutherland, I. W. (2001) The biofilm matrix-an immobilized but dynamic microbial environment Trends Microbiol. 9, 222-227 10.1016/S0966-842X(01)02012-1
204. Dibdin, G. H., Assinder, S. J., Nichols, W. W., and Lambert, P. A. (1996) Mathematical model of β-lactam penetration into a biofilm of Pseudomonas aeruginosa while undergoing simultaneous inactivation by released β-lactamases J. Antimicrob. Chemother. 38, 757-769 10.1093/jac/38.5.757
205. Qayyum, S. and Khan, A. U. (2016) Nanoparticles vs. biofilms: a battle against another paradigm of antibiotic resistance MedChemComm 7, 1479-1498 10.1039/C6MD00124F